ELTX Elicio Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$1,92
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$1,71minimo 52 sett.
$16,00massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$42M
P/E
-3.1
EPS
$-2.58
i tuoi badge
Intervallo 52 sett.
$2–$16
Rating Analisti
BUY
Prezzo Obiettivo
$14
P/E
-3.1
ROE
·
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
ELTX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$1.92
Capitalizzazione di Mercato (MRQ)
$42M
P/E
-3.1
EPS
$-2.58
D/E Debito/Patrimonio (MRQ)
1.2
Intervallo 52 sett.
$2–$16
ELTX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 02 Giugno 2023 | 1-for-10 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi·2020-12-31 → 2022-12-31
EPS$-2.582020-12-31 → 2025-12-31
Flusso di cassa libero·2021-12-31 → 2024-12-31
Margine netto·2021-12-31 → 2021-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | ELTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -3.1media 5 anni ≈-4.1 | ≈-4.1 | · | · | |
| P/B (MRQ) | 5.3 | · | 1.1 | Sopravvalutato | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 86.6 | · | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | ELTX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto (MRQ) | 1.2 | · | · | · | |
| Rapporto corrente (MRQ) | 2.8 | · | 2.9 | Bassa liquidità | |
| Debito a lungo termine / Patrimonio netto (MRQ) | 1.2 | · | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-3.1%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 13, 2026 | $-0.43 | $-0.55 | 21.5% |
| 31 Marzo 2026 | Mag 20, 2026 | $-0.65 | $-0.47 | -37.0% |
| 31 Dicembre 2025 | $-0.45 | $-0.45 | 0.86% | |
| 30 Settembre 2025 | $-0.60 | $-0.56 | -7.0% | |
| 30 Giugno 2025 | $-0.66 | $-0.70 | 5.5% | |
| 31 Marzo 2025 | $-0.87 | $-0.85 | -2.8% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $2M | $28M | $3M | |
| Cost of Revenue | · | · | · | $0 | $433.0K | $1M | |
| R&D Expense | $25M | $34M | $24M | $18M | $49M | $39M | |
| SG&A Expense | $13M | $11M | $12M | $6M | $18M | $18M | |
| Operating Expenses | $38M | $45M | $36M | $24M | $68M | $58M | |
| Operating Income | $-38M | $-45M | $-36M | $-24M | $-39M | $-55M | |
| Interest Expense | · | · | $1M | $4M | · | · | |
| Other Non-op | $-2M | $-7M | $550.0K | $-4M | $-15M | $-25M | |
| Pretax Income | $-40M | $-52M | · | $-39M | $-55M | $-80M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-52M | $-35M | $-28M | $-55M | $-80M | |
| EPS (Basic) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | |
| EPS (Diluted) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 | |
| Shares (Basic) | 15,312,751 | 12,202,996 | 5,056,225 | 315,998 | 28,244,825 | 14,762,120 | |
| Shares (Diluted) | 15,312,751 | 12,202,996 | 5,056,225 | 315,998 | 28,244,825 | 14,762,120 | |
| EBITDA | · | $-45M | · | · | $-39M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $18M | $13M | $6M | $89M | $35M | |
| Receivables | · | · | · | $0 | · | · | |
| Prepaid Expense | $748.0K | $2M | $3M | $3M | $2M | $8M | |
| Other Current Assets | · | · | · | $246.0K | $498.0K | $360.0K | |
| Current Assets | $19M | $21M | $16M | $11M | $91M | $42M | |
| PP&E (Net) | $295.0K | $483.0K | $717.0K | $1M | $451.0K | $156.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $968.0K | $582.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $517.0K | $426.0K | |
| Other Non-current Assets | · | · | · | $61.0K | $106.0K | $0 | |
| Total Assets | $26M | $28M | $27M | $23M | $97M | $47M | |
| Accounts Payable | $672.0K | $1M | $4M | $3M | $5M | $6M | |
| Accrued Liabilities | $6M | $8M | $4M | $2M | $3M | $7M | |
| Current Liabilities | $8M | $12M | $10M | $7M | $11M | $107M | |
| Capital Leases | $4M | $5M | $6M | $7M | $3M | $4M | |
| Other Non-current Liabilities | · | · | · | · | $0 | · | |
| Total Liabilities | $24M | $39M | $16M | $14M | $15M | $138M | |
| Long-term Debt | $10M | · | · | · | · | · | |
| Total Debt | · | · | · | · | $0 | · | |
| Common Stock | $178.0K | $110.0K | $96.0K | $3.0K | $300.0K | $156.0K | |
| Paid-in Capital | $235M | $183M | $154M | $5M | $296M | $72M | |
| Retained Earnings | $-234M | $-194M | $-142M | $-107M | $-215M | $-161M | |
| Treasury Stock | $150.0K | $150.0K | $150.0K | $0 | $0 | $2M | |
| AOCI | $-127.0K | $-175.0K | $-197.0K | $0 | $-103.0K | $-333.0K | |
| Stockholders' Equity | $2M | $-11M | $11M | $-102M | $-75M | $-90M | |
| Liabilities + Equity | $26M | $28M | $27M | $23M | $97M | $47M | |
| Shares Outstanding | 17,800,307 | 11,043,837 | 9,618,178 | 320,281 | 310,200 | 15,632,809 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $1M | $1M | $579.0K | $12M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | $9M | · | · | |
| Operating Cash Flow | $-37M | $-37M | $-33M | $-22M | $-53M | $-23M | |
| CapEx | $16.0K | $87.0K | $66.0K | $654.0K | $382.0K | $41.0K | |
| Investing Cash Flow | $-16.0K | $-84.0K | $-32.0K | $-654.0K | $-382.0K | $-41.0K | |
| Stock Issued | $16M | $5M | $7M | · | $107M | $-522.0K | |
| Net Stock Activity | · | $5M | · | · | $107M | · | |
| Financing Cash Flow | $37M | $42M | $39M | $21M | $107M | $52M | |
| Net Change in Cash | $-225.0K | $5M | $6M | $-2M | $54M | $29M | |
| Free Cash Flow | · | $-37M | · | · | $-53M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -138.8% | · | |
| Net Margin | · | · | · | · | -192.8% | · | |
| Pretax Margin | · | · | · | · | -192.8% | · | |
| EBITDA Margin | · | · | · | · | -138.8% | · | |
| ROA | · | -187.6% | · | · | -75.9% | · | |
| ROE | · | 342.6% | · | · | -74.8% | · | |
| ROIC | · | · | · | · | -48.2% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.8 | · | · | 8.1 | · | |
| Quick Ratio | · | 1.5 | · | · | 7.9 | · | |
| Debt / Equity | · | · | · | · | 0.0 | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $-1.03 | · | · | $2.72 | · | |
| Revenue / Share | · | · | · | · | $1.00 | · | |
| Cash Flow / Share | · | $-3.04 | · | · | $-1.86 | · | |
| Cash / Share | · | $1.60 | · | · | $2.96 | · | |
| EPS (TTM) | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -91.9% | 883.1% | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $28M | $3M | |
| Net Income TTM | $-40M | $-52M | $-35M | $-28M | $-55M | $-80M | |
| Market Cap | · | $56M | · | · | $869M | · | |
| Enterprise Value | · | · | · | · | $780M | · | |
| P/E | -3.1 | -1.2 | -1.2 | -0.1 | -15.0 | · | |
| P/S | · | 24.4 | · | · | 30.7 | · | |
| P/B | · | -5.0 | · | · | 10.7 | · | |
| P / Tangible Book | 86.6 | · | 7.0 | · | · | · | |
| P / Cash Flow | · | -1.5 | · | · | -16.5 | · | |
| P / FCF | · | -1.5 | · | · | -16.4 | · | |
| EV / EBITDA | · | · | · | · | -19.8 | · | |
| EV / FCF | · | · | · | · | -14.7 | · | |
| EV / Revenue | · | · | · | · | 27.6 | · | |
| Earnings Yield | -32.4% | -83.3% | -83.5% | -1099.4% | -6.7% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| R&D Expense | $7M | $7M | $5M | $5M | $7M | $8M | $11M | $7M | $8M | $8M | $6M | $7M | $5M | $5M | $-3M | $5M | |
| SG&A Expense | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $2M | $-1M | $1M | |
| Operating Expenses | $10M | $11M | $9M | $8M | $10M | $11M | $13M | $10M | $11M | $10M | $9M | $11M | $8M | $8M | $-4M | $6M | |
| Operating Income | $-10M | $-11M | $-9M | $-8M | $-10M | $-11M | $-13M | $-10M | $-11M | $-10M | $-9M | $-11M | $-8M | $-8M | $3M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $36.0K | · | $1.0K | $714.0K | $342.0K | $92.0K | $1M | |
| Interest Income | $138.0K | $157.0K | · | $199.0K | $168.0K | $210.0K | · | $185.0K | $137.0K | · | · | $246.0K | $39.0K | · | · | · | |
| Other Non-op | $2M | $-1M | $1M | $-2M | $-470.0K | $-473.0K | $-527.0K | $-8M | $4M | $-2M | $443.0K | $113.0K | $218.0K | $-224.0K | $-2M | $-1M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-12M | $-8M | $-10M | $-11M | $-11M | $-14M | $-19M | $-7M | $-12M | $-9M | $-11M | $-8M | $-8M | $-7M | $-7M | |
| EPS (Basic) | $-0.43 | $-0.65 | $-0.45 | $-0.60 | $-0.66 | $-0.87 | $-1.07 | $-1.39 | $-0.64 | $-1.15 | $21.69 | $-1.27 | $-2.61 | $-24.77 | $-42.92 | $-22.67 | |
| EPS (Diluted) | $-0.43 | $-0.65 | $-0.45 | $-0.60 | $-0.66 | $-0.87 | $-1.07 | $-1.39 | $-0.64 | $-1.15 | $21.69 | $-1.27 | $-2.61 | $-24.77 | $-42.92 | $-22.67 | |
| Shares (Basic) | 19,244,679 | 18,211,745 | · | 16,692,476 | 16,059,423 | 12,950,574 | · | 13,582,345 | 11,284,853 | 10,273,925 | · | 8,376,384 | 2,893,244 | 324,106 | · | 317,512 | |
| Shares (Diluted) | 19,244,679 | 18,211,745 | · | 16,692,476 | 16,059,423 | 12,950,574 | · | 13,582,345 | 11,284,853 | 10,273,925 | · | 8,376,384 | 2,893,244 | 324,106 | · | 317,512 | |
| EBITDA | $-10M | $-11M | · | $-8M | $-10M | $-11M | · | $-10M | $-11M | $-10M | · | $-11M | $-8M | $-5M | · | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $15M | $19M | $21M | $22M | $18M | $18M | $26M | $3M | $12M | $13M | $15M | $22M | $29M | $6M | $55M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | $10M | · | · | |
| Prepaid Expense | $2M | $1M | $748.0K | $854.0K | $510.0K | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $2M | $3M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $405.0K | · | $326.0K | |
| Current Assets | $25M | $16M | $19M | $21M | $23M | $21M | $21M | $31M | $7M | $14M | $16M | $20M | $26M | $41M | $11M | $57M | |
| PP&E (Net) | $213.0K | $249.0K | $295.0K | $328.0K | $377.0K | $430.0K | $483.0K | $523.0K | $597.0K | $635.0K | $717.0K | $772.0K | $919.0K | $0 | $1M | $304.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $0 | $2M | $968.0K | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $0 | $1M | $664.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | $864.0K | · | $75.0K | |
| Total Assets | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M | $24M | $27M | $31M | $38M | $42M | $23M | $61M | |
| Accounts Payable | $839.0K | $272.0K | $672.0K | $321.0K | $4M | $4M | $1M | $2M | $1M | $1M | $4M | $4M | $4M | $692.0K | $3M | $2M | |
| Accrued Liabilities | $7M | $6M | $6M | $5M | $5M | $6M | $8M | $5M | $5M | $3M | $4M | $4M | $2M | $1M | $2M | $5M | |
| Current Liabilities | $9M | $7M | $8M | $7M | $10M | $11M | $12M | $9M | $8M | $6M | $10M | $11M | $8M | $2M | $7M | $8M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $70.0K | $7M | $3M | |
| Total Liabilities | $23M | $24M | $24M | $24M | $28M | $19M | $39M | $57M | $17M | $20M | $16M | $18M | $14M | $2M | $14M | $11M | |
| Long-term Debt | · | · | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $10M | $9M | · | $10M | $9M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $219.0K | $186.0K | $178.0K | $173.0K | $163.0K | $160.0K | $110.0K | $108.0K | $103.0K | $102.0K | $96.0K | $84.0K | $84.0K | $301.0K | $3.0K | $301.0K | |
| Paid-in Capital | $262M | $244M | $235M | $230M | $218M | $214M | $183M | $161M | $160M | $159M | $154M | $147M | $146M | $298M | $5M | $297M | |
| Retained Earnings | $-254M | $-245M | $-234M | $-226M | $-216M | $-205M | $-194M | $-180M | $-161M | $-154M | $-142M | $-133M | $-123M | $-258M | $-107M | $-248M | |
| Treasury Stock | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | $150.0K | · | $0 | · | |
| AOCI | $-126.0K | $-122.0K | $-127.0K | $-31.0K | $-70.0K | $-144.0K | $-175.0K | $-202.0K | $-238.0K | $-270.0K | $-197.0K | $-25.0K | $-2.0K | $165.0K | $0 | $302.0K | |
| Stockholders' Equity | $8M | $-1M | $2M | $4M | $2M | $9M | $-11M | $-19M | $-2M | $5M | $11M | $13M | $24M | $40M | $-102M | $50M | |
| Liabilities + Equity | $31M | $23M | $26M | $28M | $30M | $28M | $28M | $38M | $16M | $24M | $27M | $31M | $38M | $42M | $23M | $61M | |
| Shares Outstanding | 21,901,569 | 18,639,895 | 17,800,307 | 17,258,652 | 16,262,932 | 15,968,736 | 11,029,382 | 10,784,377 | 10,258,873 | 10,219,989 | 9,603,723 | 8,378,361 | 8,370,268 | 30,114,190 | 320,281 | 30,113,582 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $935.0K | $868.0K | $772.0K | $698.0K | $710.0K | $517.0K | $464.0K | $314.0K | $350.0K | $324.0K | $337.0K | $339.0K | $151.0K | $224.0K | $199.0K | $-1M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $-8M | $-12M | $-7M | $-11M | $-9M | $-10M | $-9M | $-7M | $-9M | $-12M | $-10M | $-5M | $-10M | $-8M | $-7M | $11M | |
| CapEx | · | · | $16.0K | $0 | · | · | $45.0K | $0 | $42.0K | $0 | $0 | $45.0K | $4.0K | $17.0K | $95.0K | $559.0K | |
| Investing Cash Flow | · | · | $-16.0K | $0 | $0 | $0 | $-45.0K | $0 | $-42.0K | $3.0K | $0 | $-45.0K | $10M | $-17.0K | $-95.0K | $-559.0K | |
| Stock Issued | · | · | · | · | $2M | $835.0K | $-858.0K | $48.0K | $303.0K | $5M | $7M | $0 | $0 | $0 | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $835.0K | · | · | · | $5M | · | · | · | · | · | · | |
| Financing Cash Flow | $17M | $8M | $5M | $10M | $12M | $10M | $227.0K | $31M | $316.0K | $11M | $7M | $60.0K | $35M | $10M | $11M | $10M | |
| Net Change in Cash | $8M | $-4M | $-2M | $-1M | $3M | $240.0K | $-9M | $24M | $-9M | $-1M | $-3M | $-5M | $35M | $2M | $4M | $20M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-12M | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -27.0% | -46.5% | · | -30.2% | -46.7% | -42.6% | · | -54.3% | -27.1% | -35.7% | · | -23.1% | -13.9% | -7.4% | · | -10.5% | |
| ROE | -168.2% | -316.7% | · | 132.9% | -11605.5% | -162.8% | · | 661.0% | -66.0% | -53.1% | · | -33.6% | -18.1% | -8.5% | · | -15.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.2 | · | 3.3 | 2.3 | 1.8 | · | 3.4 | 0.9 | 2.4 | · | 1.7 | 3.5 | 20.0 | · | 6.9 | |
| Quick Ratio | 2.6 | 2.1 | · | 3.2 | 2.2 | 1.6 | · | 2.9 | 0.5 | 2.0 | · | 1.3 | 2.9 | 19.2 | · | 6.7 | |
| Debt / Equity | 1.2 | -6.6 | · | 2.5 | 5.1 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 1.2 | -6.6 | · | 2.5 | 5.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -284.5 | · | -10771.0 | -10.9 | · | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.36 | $-0.08 | · | $0.22 | $0.11 | $0.56 | · | $-1.76 | $-0.16 | $0.48 | · | $1.59 | $2.81 | $1.32 | · | $1.67 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.64 | · | · | · | $-0.78 | · | · | · | $-1.18 | · | · | · | $-0.27 | · | · | |
| Cash / Share | $1.07 | $0.80 | · | $1.19 | $1.36 | $1.15 | · | $2.41 | $0.33 | $1.16 | · | $1.77 | $2.59 | $0.97 | · | $1.83 | |
| EPS (TTM) | $-2.13 | $-2.36 | · | $-3.20 | $-3.99 | $-3.97 | · | $18.51 | $18.63 | $16.66 | · | $-71.57 | $-92.97 | $-113.56 | · | $-45.61 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Net Income TTM | $-38M | $-40M | · | $-46M | $-55M | $-51M | · | $-47M | $-39M | $-39M | · | $-33M | $-29M | $-29M | · | $-7M | |
| Market Cap | $86M | $199M | · | $189M | $126M | $98M | · | $54M | $42M | $78M | · | $71M | $80M | $175M | · | $277M | |
| Enterprise Value | $72M | $194M | · | $178M | $113M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -4.5 | · | -3.4 | -1.9 | -1.6 | · | 0.3 | 0.2 | 0.5 | · | -0.1 | -0.1 | -0.1 | · | -0.2 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 9.8 | |
| P/B | 10.8 | -138.7 | · | 49.5 | 68.5 | 11.0 | · | -2.9 | -25.5 | 15.9 | · | 5.3 | 3.4 | 4.4 | · | 5.5 | |
| P / Tangible Book | 10.8 | · | · | 49.5 | 68.5 | 11.0 | · | · | · | 15.9 | · | 5.3 | 3.4 | 4.4 | · | 5.5 | |
| P / Cash Flow | · | -17.1 | · | · | · | -9.7 | · | · | · | -6.4 | · | · | · | -21.6 | · | · | |
| Earnings Yield | -54.5% | -22.1% | · | -29.2% | -51.7% | -64.5% | · | 368.0% | 453.3% | 219.2% | · | -847.0% | -978.6% | -1957.9% | · | -495.8% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | · | · | · | $2M | $28M |
| Margine Operativo % | · | · | · | · | -138.8% |
| Utile netto | $-40M | $-52M | $-35M | $-28M | $-55M |
| EPS Diluito | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | · | · | · | · | 0.0 |
| Rapporto corrente | · | 1.8 | · | · | 8.1 |
| Quick Ratio | · | 1.5 | · | · | 7.9 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | $-37M | · | · | $-53M |
Proprietari istituzionali (13F) 67 filer · $26.7M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
67
Valore detenuto
$26.7M
Nuove posizioni
35
Posizioni chiuse
22
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 35 (+12 vs trimestre precedente) | 22 (+15 vs trimestre precedente) | 17 (+3 vs trimestre precedente) | 6 (-2 vs trimestre precedente) | +2.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Knoll Capital Management, LLC | $4.738.751 | 1.211.957 | 17,78% | Azioni |
| VANGUARD GROUP INC | $3.955.331 | 496.901 | 14,84% | Azioni |
| BlackRock, Inc. | $2.995.079 | 766.005 | 11,24% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.237.110 | 572.151 | 8,39% | Azioni |
| Caption Management, LLC | $1.634.771 | 418.100 | 6,13% | Opzione Call |
| GEODE CAPITAL MANAGEMENT, LLC | $1.217.614 | 311.354 | 4,57% | Azioni |
| TORONTO DOMINION BANK | $782.000 | 200.000 | 2,93% | Opzione Call |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $709.274 | 181.400 | 2,66% | Opzione Call |
| STATE STREET CORP | $701.532 | 179.420 | 2,63% | Azioni |
| Caption Management, LLC | $647.887 | 165.700 | 2,43% | Opzione Put |
| JANE STREET GROUP, LLC | $600.576 | 153.600 | 2,25% | Opzione Put |
| CITADEL ADVISORS LLC | $524.722 | 134.200 | 1,97% | Opzione Call |
| NORTHERN TRUST CORP | $508.933 | 130.162 | 1,91% | Azioni |
| DIADEMA PARTNERS LP | $438.311 | 112.100 | 1,64% | Opzione Call |
| Ikarian Capital, LLC | $418.761 | 107.100 | 1,57% | Opzione Call |
| Ikarian Capital, LLC | $418.761 | 107.100 | 1,57% | Opzione Put |
| Ikarian Capital, LLC | $391.000 | 100.000 | 1,47% | Azioni |
| DIADEMA PARTNERS LP | $391.000 | 100.000 | 1,47% | Opzione Put |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $352.291 | 90.100 | 1,32% | Opzione Put |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $347.619 | 88.905 | 1,30% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $344.322 | 88.062 | 1,29% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $317.805 | 81.280 | 1,19% | Azioni |
| UBS Group AG | $158.039 | 40.419 | 0,59% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $126.684 | 32.400 | 0,48% | Opzione Call |
| BOOTHBAY FUND MANAGEMENT, LLC | $126.684 | 32.400 | 0,48% | Opzione Put |
| JANE STREET GROUP, LLC | $126.684 | 32.400 | 0,48% | Opzione Call |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $123.970 | 31.706 | 0,47% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $119.998 | 30.690 | 0,45% | Azioni |
| MORGAN STANLEY | $99.885 | 25.546 | 0,37% | Azioni |
| Leonteq Securities AG | $78.200 | 20.000 | 0,29% | Azioni |
| Nuveen, LLC | $69.942 | 17.888 | 0,26% | Azioni |
| CITIGROUP INC | $69.309 | 17.726 | 0,26% | Azioni |
| Bank of New York Mellon Corp | $62.107 | 15.884 | 0,23% | Azioni |
| CITADEL ADVISORS LLC | $58.650 | 15.000 | 0,22% | Opzione Put |
| NEW YORK STATE COMMON RETIREMENT FUND | $55.522 | 14.200 | 0,21% | Azioni |
| MEYER HANDELMAN CO | $54.345 | 13.899 | 0,20% | Azioni |
| HighTower Advisors, LLC | $53.434 | 13.666 | 0,20% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $49.735 | 12.720 | 0,19% | Azioni |
| DEUTSCHE BANK AG\ | $49.469 | 12.652 | 0,19% | Azioni |
| WELLS FARGO & COMPANY/MN | $46.228 | 11.823 | 0,17% | Azioni |
| CIBC Private Wealth Group LLC | $42.560 | 7.000 | 0,16% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $41.663 | 11.972 | 0,16% | Azioni |
| HB Wealth Management, LLC | $40.910 | 10.463 | 0,15% | Azioni |
| Summit Financial, LLC | $39.120 | 10.005 | 0,15% | Azioni |
| Mayflower Financial Advisors, LLC | $39.100 | 10.000 | 0,15% | Azioni |
| MOODY LYNN LIEBERSON & WALKER, LLC | $39.100 | 10.000 | 0,15% | Azioni |
| &PARTNERS | $39.100 | 10.000 | 0,15% | Azioni |
| RHUMBLINE ADVISERS | $26.119 | 6.681 | 0,10% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $23.331 | 5.967 | 0,09% | Azioni |
| JPMORGAN CHASE & CO | $21.488 | 5.372 | 0,08% | Azioni |
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| GKCC, LLC, Yekaterina Chudnovsky | 04 Giugno 2025 | 48,00% | Modifica | · | SEC |
| Yekaterina Chudnovsky, GKCC, LLC ×6 depositi | 07 Marzo 2025 | 48,10% | Modifica | · | SEC |
| Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, Clal Industries Ltd., Clal Biotechnology Industries Ltd., Len Blavatnik ×5 depositi | 10 Aprile 2024 | · | Deposito iniziale | · | SEC |
| Jay R. Venkatesan, M.D. | 14 Giugno 2023 | · | Deposito iniziale | M&A / vendita | SEC |
| Jay R. Venkatesan | 27 Aprile 2022 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 19 insider · 8 dirigenti · 11 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Robert Connelly | CEO, President and Director | 16 Luglio 2026 A | 120.570 | 0 | 0 | $0 |
| Brian Piekos | Chief Financial Officer | 01 Febbraio 2024 A | · | 0 | 0 | $0 |
| Gregory S Curhan | Chief Financial Officer | 02 Marzo 2022 A | 4.000 | 0 | 0 | $0 |
| Peter Demuth | Chief Scientific Officer | 16 Luglio 2026 A | 21.543 | 0 | 0 | $0 |
| Preetam Shah | Chief Strategy and Financial Officer | 16 Luglio 2026 A | 24.000 | 0 | 0 | $0 |
| Christopher Haqq | Executive Vice President, Head of R&D and Chief Medical Officer | 16 Luglio 2026 A | 57.381 | 0 | 0 | $0 |
| John F. Neylan | Executive Vice President, Chief Medical Officer and Head of Research | 02 Marzo 2022 A | 35.136 | 0 | 0 | $0 |
| Jennifer J Rhodes | Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Secretary | 02 Marzo 2022 A | 30.399 | 0 | 0 | $0 |
| Yekaterina Chudnovsky | Direttore | 31 Agosto 2026 A | · | 0 | 0 | $0 |
| Carol Gail Ashe | Direttore | 31 Agosto 2026 A | · | 0 | 0 | $0 |
| Allen Nissenson | Direttore | 31 Agosto 2026 A | 9.383 | 0 | 0 | $0 |
| Jay Venkatesan | Direttore | 31 Agosto 2026 A | 179.581 | 0 | 0 | $0 |
| Karen J Wilson | Direttore | 31 Agosto 2026 A | 18.718 | 0 | 0 | $0 |
| Julian Adams | Direttore | 31 Agosto 2026 A | · | 0 | 0 | $0 |
| Robert R Ruffolo | Direttore | 31 Agosto 2026 A | · | 0 | 0 | $0 |
| Itzhak Goldberg | Direttore | 01 Luglio 2022 F | 1.687.986 | 0 | 0 | $0 |
| Victor F Ganzi | Direttore | 09 Giugno 2022 A | 823.117 | 0 | 0 | $0 |
| Gilbert S Omenn | Direttore | 09 Giugno 2022 A | 80.326 | 0 | 0 | $0 |
| EISA-ABC LLC | Proprietario del 10% | 31 Agosto 2021 J | 2.740.978 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 8 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 43.429 SH | 11 Settembre 2026 | Giornaliero |
| IWO · iShares Trust | 0,00% | 121.695 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,00% | 6.202 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 312.895 SH | 11 Settembre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 143.596 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 415.401 SH | 19 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 74.933 SH | 19 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.972 SH | 19 Agosto 2026 | Giornaliero |
ELTX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 10 analisti
COMPRA
Target mediano
$10.00
+420,8%
3 30,0%
Acquisto forte
5 50,0%
Compra
2 20,0%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-10-03Target medio $13.67 +611,8%
← Sotto tutti i target
Prezzo attuale $1.92
Basso$8.00
Media$13.67
Alto$23.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026